IP Verse

Teijin Pharma competitive analysis

Latest publications and patents of Teijin Pharma New

Explore the latest publications and patents granted to Teijin Pharma, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Teijin Pharma
EP1956014	Jan 16, 2019	Polymorphs Of 2-(3-Cyano-4-Isobutyloxyphenyl)-4-Methyl-5-Thiazolecarboxylic Acid And Method Of Producing The Same	Revoked
EP2944633	Jan 31, 2018	Pyridine Derivative	No Opposition Filed Within Time Limit

Latest patents of Teijin Pharma opposed by its competitors

Explore Teijin Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP1956014	Jan 16, 2019	Polymorphs Of 2-(3-Cyano-4-Isobutyloxyphenyl)-4-Methyl-5-Thiazolecarboxylic Acid And Method Of Producing The Same	1

Latest PTAB cases involving Teijin Pharma

Discover the latest PTAB cases involving Teijin Pharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Teijin Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
TEIJIN PHARMA	-	1	-	-	Non-Active
DR SCHON	27	-	-	-	Highly Aggressive